Prostate cancer (PCa) is witnessing a concerning rise in incidence annually, with the
androgen receptor (AR) emerging as a pivotal contributor to its growth and progression …

Androgen receptor (AR) transcriptional activity significantly influences prostate cancer (PCa)
progression. In addition to ligand stimulation, AR transcriptional activity is also influenced by …

Androgens, acting through the androgen receptor (AR), are responsible for many male
reproductive and nonreproductive functions. Moreover, aberrant androgen/AR signaling …

Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading
cause of cancer death in western men, and as such constitutes a significant health problem …

Prostate cancer is the most common cancer in men in the United States, and it is the second
leading cause of cancer‐related death in American men. The androgen receptor (AR), a …

The androgen-signaling axis plays a pivotal role in the pathogenesis of prostate cancer.
Since the landmark discovery by Huggins and Hodges, gonadal depletion of androgens has …

Prostate cancer (PCa) progression relies on androgen receptor (AR) action. Preventing AR's
ligand-activation is the frontline treatment for metastatic PCa. Androgen deprivation therapy …

Prostate cancer is the most commonly diagnosed cancer in men all over the world.
Localized cancers in the early stages can be well managed by surgical or radiation therapy …

Prostate cancer (PCa) is the most commonly diagnosed cancer among men in western
countries. Androgen receptor (AR) signaling plays key roles in the development of PCa …

Androgens play a key role in the development and progression of prostate cancer, and
androgen deprivation therapy (ADT) is the first line treatment for advanced disease …